CN106038849A - Antiviral oral liquid - Google Patents
Antiviral oral liquid Download PDFInfo
- Publication number
- CN106038849A CN106038849A CN201610308970.7A CN201610308970A CN106038849A CN 106038849 A CN106038849 A CN 106038849A CN 201610308970 A CN201610308970 A CN 201610308970A CN 106038849 A CN106038849 A CN 106038849A
- Authority
- CN
- China
- Prior art keywords
- parts
- oral liquid
- radix
- herba houttuyniae
- folium isatidis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 16
- 230000000840 anti-viral effect Effects 0.000 title abstract description 5
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 230000002155 anti-virotic effect Effects 0.000 claims description 10
- 241000628997 Flos Species 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- PQTCMBYFWMFIGM-UHFFFAOYSA-N gold silver Chemical compound [Ag].[Au] PQTCMBYFWMFIGM-UHFFFAOYSA-N 0.000 claims description 2
- 238000003672 processing method Methods 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- 235000014676 Phragmites communis Nutrition 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 5
- 210000004369 blood Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 208000015220 Febrile disease Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 241001263478 Norovirus Species 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/78—Saururaceae (Lizard's-tail family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
- A61K36/855—Clerodendrum, e.g. glorybower
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Neurosurgery (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to antiviral oral liquid, which is prepared from the following raw materials in parts by weight: 8-15 parts of radix scutellariae, 10-20 parts of rhizoma belamcandae, 12-25 parts of folium isatidis, 8-16 parts of honeysuckle flowers, 14-20 parts of radix et rhizoma rhei and 14-18 parts of herba houttuyniae. The antiviral oral liquid prepared by the invention has functions of clearing heat and eliminating dampness, cooling blood and removing toxic materials, and the antiviral oral liquid is suitable for treating anemopyretic cold and flu.
Description
Technical field
The invention belongs to field of medicaments, be specifically related to a kind of antivirus oral liquid.
Background technology
In recent years, reported that increasing virus infects the death caused, such as SARS (serious acute respiratory system
System syndrome), norovirus (norovirus) and bird flu.Due to day by day flourishing transportation network and the disease of constantly variation
Poison, the most popular prospect causes global threat now.The appearance of new influenza virus is also that needs are prompt urgent
Problem.Although exploitation antiviral vaccine is a solution of these problems and carries out the most peremptorily, but by
In the specificity of vaccine, they are only effective in terms of the infection of suppression specific virus.Because production of vaccine is that needs are quite a lot of
The process of time, so being generally difficult to lay in the specific vaccine of demand.Thus, this for table equal to various viruses
The demand of the antiviral agent revealing antiviral activity is the most vigorous.
Summary of the invention
It is an object of the invention to provide a kind of antivirus oral liquid.
The present invention is achieved by the following technical solutions:
A kind of antivirus oral liquid, including following weight ratio raw material: Radix Scutellariae 8-15 part, Rhizoma Belamcandae 10-20 part, Folium Isatidis 12-25 part,
Flos Lonicerae 8-16 part, Radix Et Rhizoma Rhei 14-20 part, Herba Houttuyniae 14-18 part.
Described optimum quality ratio is: Radix Scutellariae 11.5 parts, Rhizoma Belamcandae 15 parts, Folium Isatidis 18.5 parts, Flos Lonicerae 12 parts, Radix Et Rhizoma Rhei 17
Part, Herba Houttuyniae 16 parts.
Described processing method comprises the following steps: take Radix Scutellariae, Rhizoma Belamcandae, Folium Isatidis 3 taste medical material, adds the decocting of 8 times of quality
Boil 2 times, each 2h, merge decoction liquor, filter standby；Flos Lonicerae, Radix Et Rhizoma Rhei, Herba Houttuyniae 3 taste medical material add the 80% of 6 times of quality
Alcohol reflux 2 times, each 1h, extracting solution filters, is mixed into above-mentioned reserve liquid, concentrating under reduced pressure.
The medicine of the present invention has the effect such as clearing heat and expelling damp, removing pathogenic heat from blood and toxic substance from the body, for anemopyretic cold, influenza.
Pharmacology analysis:
Radix Scutellariae: cure mainly epidemic febrile disease, upper respiratory tract infection, cough due to lung-heat, damp and hot jaundice, pneumonia, dysentery, hemoptysis, conjunctival congestion, fetal movement not
The diseases such as peace, hypertension, carbuncle furuncle.
Rhizoma Belamcandae: be used for experiencing wind heat, or expectorant heat stops up the diseases such as the laryngopharynx swelling and pain caused by containing.
Folium Isatidis: send out the diseases such as speckle, erysipelas, laryngopharynx swelling and pain, aphtha of the mouth and tongue, sore and toxic for pyretic toxicity.
Flos Lonicerae: heat-clearing and toxic substances removing, dispelling wind and heat pathogens, cure mainly carbuncle furunculosis from the beginning of, red and swollen heat pain, affection due to external wind and heat, epidemic febrile disease from the beginning of,
Toxic-heat and blood stasis, summer-heat excessive thirst, laryngopharynx swelling and pain.
Radix Et Rhizoma Rhei: attack stagnant, clearing away damp-heat, pathogenic fire purging, removing heat from blood, blood stasis dispelling, removing toxic substances.
Herba Houttuyniae: heat-clearing and toxic substances removing, eliminating carbuncle evacuation of pus, inducing diuresis to remove edema, treating stranguria.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further detail, but embodiments of the present invention are not limited to this.
Embodiment 1:
A kind of antivirus oral liquid, including following weight ratio raw material: Radix Scutellariae 8 parts, Rhizoma Belamcandae 10 parts, Folium Isatidis 12 parts, Flos Lonicerae 8
Part, Radix Et Rhizoma Rhei 14 parts, Herba Houttuyniae 14 parts.
Embodiment 2:
A kind of antivirus oral liquid, including following weight ratio raw material: Radix Scutellariae 15 parts, Rhizoma Belamcandae 20 parts, Folium Isatidis 25 parts, Flos Lonicerae 16
Part, Radix Et Rhizoma Rhei 20 parts, Herba Houttuyniae 18 parts.
Embodiment 3:
A kind of antivirus oral liquid, including following weight ratio raw material: Radix Scutellariae 11.5 parts, Rhizoma Belamcandae 15 parts, Folium Isatidis 18.5 parts, gold silver
Spend 12 parts, Radix Et Rhizoma Rhei 17 parts, Herba Houttuyniae 16 parts.
Claims (3)
1. an antivirus oral liquid, it is characterised in that include following weight ratio raw material: Radix Scutellariae 8-15 part, Rhizoma Belamcandae 10-20 part, big
Folium Isatidis 12-25 part, Flos Lonicerae 8-16 part, Radix Et Rhizoma Rhei 14-20 part, Herba Houttuyniae 14-18 part.
2. antivirus oral liquid as claimed in claim 1 a kind of, it is characterised in that optimum quality ratio is: Radix Scutellariae 11.5 parts, penetrate
Dry 15 parts, Folium Isatidis 18.5 parts, Flos Lonicerae 12 parts, Radix Et Rhizoma Rhei 17 parts, Herba Houttuyniae 16 parts.
3. a kind of antivirus oral liquid as claimed in claim 1, it is characterised in that processing method comprises the following steps: take Huang
A kind of reed mentioned in ancient books, Rhizoma Belamcandae, Folium Isatidis 3 taste medical material, the soak by water of 8 times of quality of addition 2 times, each 2h, merge decoction liquor, filter standby；Gold silver
The alcohol reflux of the 80% of flower, Radix Et Rhizoma Rhei, Herba Houttuyniae 3 taste medical material 6 times of quality of addition 2 times, each 1h, extracting solution filters, is mixed into
Above-mentioned reserve liquid, concentrating under reduced pressure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610308970.7A CN106038849A (en) | 2016-05-11 | 2016-05-11 | Antiviral oral liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610308970.7A CN106038849A (en) | 2016-05-11 | 2016-05-11 | Antiviral oral liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106038849A true CN106038849A (en) | 2016-10-26 |
Family
ID=57176876
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610308970.7A Pending CN106038849A (en) | 2016-05-11 | 2016-05-11 | Antiviral oral liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106038849A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109485706A (en) * | 2018-11-02 | 2019-03-19 | 浙江省疾病预防控制中心 | A kind of cordate houttuynia glycoprotein and its preparation and application |
-
2016
- 2016-05-11 CN CN201610308970.7A patent/CN106038849A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109485706A (en) * | 2018-11-02 | 2019-03-19 | 浙江省疾病预防控制中心 | A kind of cordate houttuynia glycoprotein and its preparation and application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102961439B (en) | Total flavone extract of Hyssopus officinalis, preparation method thereof and application thereof | |
| CN104383332A (en) | Compound Ganmaoling granules and preparation method thereof | |
| CN106070838A (en) | The manufacture method of Usnea balm flower health tea | |
| Deng et al. | Antiviral activity of Folium isatidis derived extracts in vitro and in vivo | |
| CN101584836B (en) | Detoxifying Chinese medicament and preparation method thereof | |
| CN106038849A (en) | Antiviral oral liquid | |
| CN104510986A (en) | Flos abelmoschus manihot health care medicinal liquor medicinal liquor | |
| CN103877458A (en) | Compound Chinese herbal medicine for promoting lutjanus sanguineus growth and preparation method thereof | |
| CN105194419B (en) | Resisiting influenza virus herbal composite | |
| CN103961441A (en) | Traditional Chinese medicine compound preparation, preparation method and medicine box thereof | |
| CN101612197B (en) | Baikal skullcap root composition with activity of anti-enteroviruses and/or influenza virus A type agent | |
| CN105477231A (en) | Traditional Chinese medicine prescription for treating pulmonary abscess | |
| CN106668230A (en) | Traditional Chinese medicine formula for treating wind-cold type nasal obstruction | |
| CN106377714A (en) | Application of Zukamu granules in preparing medicine for treating virus flu | |
| CN106063827A (en) | A kind of viral infection resisting electuary | |
| CN106038848A (en) | Antiviral traditional Chinese medicinal composition | |
| CN106038731A (en) | Anti-toxic agent | |
| CN106668501A (en) | Traditional Chinese medicine formula for treating yin deficiency-type atrophic rhinitis | |
| CN103536762B (en) | A kind of Chinese medicine for the treatment of chronic mediastinitis | |
| CN103690858B (en) | A kind of Chinese medicine treating benign biliary stricture | |
| CN104000908A (en) | Traditional Chinese medicine for treating pediatric pneumonia and preparation method thereof | |
| CN102973644A (en) | Drug for treating acute or chronic hepatitis, and preparation method thereof | |
| CN102327504A (en) | Chinese herbal medicine for treating measles | |
| CN109566809A (en) | A kind of preparation method of radix tetrastigme nutrition and health care jasmine tea | |
| CN106668175A (en) | Traditional Chinese medicine formula for treating wind heat type cold and stuffy nose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161026 |